Three-Year Follow-Up after Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Treating Diabetic Macular Edema: The ILUVI1MOIS Study
Ophthalmologica · 27.03.2026 · 1-12
DOI: 10.1159/000551760 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmologica, online erschienen am 27.03.2026. Verfasst von Lisa Delperier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, CHU Nantes, Nantes University, Nantes, France. Hauptthemen laut MEDLINE: Fluocinolone Acetonide, Macular Edema, Dexamethasone, Diabetic Retinopathy. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
The aim of this multicenter study was to assess the efficacy and safety of injecting a fluocinolone acetonide implant (FACi) 1 month after the last dexamethasone implant (DEXi) intravitreal injection (IVI) in chronic diabetic macular edema (DME) patients.
Methods
This retrospective study evaluated a standardized care protocol implemented across 5 centers. Inclusion criteria were as follows: pseudophakic, chronic DME treated with DEXi every 30 mm Hg” event was 2.7% [0.0; 12.2] at M12 and 18.8% [7.2; 34.4] at M36. One patient underwent incisional surgery (Xen stent implantation).
Conclusion
Injecting FACi 1 month after the last DEXi in patients requiring DEXi IVI every
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, CHU Nantes, Nantes University, Nantes, France.
- Nantes University, CHU Nantes, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413, Nantes, France.
- Centre Hospitalier Universitaire de Rennes, Service d'Ophtalmologie, Rennes, France.
- Centre Hospitalier Le Mans, Service d'Ophtalmologie, Le Mans, France.
- Hôpital Universitaire Bretonneau, Service d'Ophtalmologie, Tours, France.
- Hôpital Universitaire Bretonneau, Service d'Ophtalmologie, UMR 1253, iBrain, Tours, France.
Zitieren
APA
Delperier, L., Rousseau, N., Goronflot, T. C. V., Henry, A., Lebreton, O., Massé, H., Maucourant, Y., Pipelart, V., Clément, M., Le Lez, M. L., Khanna, R. K., Mainguy, A., Weber, M., Poinas, A., & Ducloyer, J. B. (2026). Three-Year Follow-Up after Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Treating Diabetic Macular Edema: The ILUVI1MOIS Study. Ophthalmologica, 1-12. https://doi.org/10.1159/000551760
Vancouver
Delperier L, Rousseau N, Goronflot TCV, Henry A, Lebreton O, Massé H, et al. Three-Year Follow-Up after Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Treating Diabetic Macular Edema: The ILUVI1MOIS Study. Ophthalmologica. 2026:1-12. doi:10.1159/000551760
BibTeX
@article{Delperier2026,
author = {Delperier, Lisa and Rousseau, Nicolas and Goronflot, Thomas Charles Victor and Henry, Alexy and Lebreton, Olivier and Massé, Hélène and Maucourant, Yann and Pipelart, Valentin and Clément, Manon and Le Lez, Marie-Laure and Khanna, Raoul Kanav and Mainguy, Adam and Weber, Michel and Poinas, Alexandra and Ducloyer, Jean-Baptiste},
title = {Three-Year Follow-Up after Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Treating Diabetic Macular Edema: The ILUVI1MOIS Study},
journal = {Ophthalmologica},
year = {2026},
pages = {1--12},
doi = {10.1159/000551760}
}
EUVIMED